- Founded by Garrett Brown, famous inventor of the Steadicam, Skycam and other industry-transforming inventions; and inductee into the National Inventors Hall of Fame
- Investors include strategic investor Select Medical and Founders Fund
- Patented, differentiated technology allowing users to sit, stand, move and rest all while supported
- Case studies and testimonials from users have describe the Zeen as "life-changing" and a "better way of life"
- Portfolio of one issued and four pending patents managed by founder Garrett Brown, an experienced inventor with over 100 issued patents worldwide
- Total Amount Raised: US $192,634
- Total Round Size: US $4,000,000
- Series B :
- Minimum Investment: US $1,000 per investor
- : Preferred Equity
- US $25,000,000 :
- Side by Side Offering
One-in-seven of us are at risk of losing mobility due to a number of causes including illness, age or injury. Mobility loss erodes independence, restricts daily activities, and can bring on health complications ranging from infections to depression.
Over 47,000 Americans are treated each year for falls while using a walker or cane. And the ability to stand comfortably and safely -- something few mobility aids can offer -- has been found to be beneficial for cardiac, circulatory, muscular, digestive, and even psychological fitness as one can remain eye-to-eye in social situations.
Hall-of-Fame inventor Garrett Brown – father of the Steadicam and Skycam, which revolutionized moviemaking and sports broadcasting – watched his own parents struggle with walkers (described as “slow", "in-the-way", "not cool”) and wheelchairs (“a one-way ticket to not walking”) and knew something serious was missing.
In 2015, Brown and partners founded Exokinetics, Inc. to pursue their vision for mobility technology: weightless transition between seated and standing, safe strolling and coasting, sociable relaxing in ‘barstool mode’, and hands-free access for lifestyle tasks.
A unique invention, the Zeen® uses proprietary technology to help users get up-and-about and moving with confidence.
After six years of development, the lightweight, folding Zeen began shipping to customers in March 2022. Users have described it as “life-changing”, “unlike anything I have ever experienced”, and simply a “better way of life.” Demand from initial marketing efforts has outpaced the company’s manufacturing capacity.
Future products planned by Exokinetics include pediatric Zeens and unique devices for patient-lifting and transport.
A Side by Side offering refers to a deal that is raising capital under two offering types. Investments made through the SeedInvest platform are offered via Regulation CF and subject to investment limitations further described in the Form C and/or subscription documents. Investments made outside of the SeedInvest platform are offered via Regulation D and requires one to be a verified accredited investor in order to be eligible to invest.
US $92,635 (under Reg CF only)
Investors who invest less than $50,000 will have their securities held in trust with a Custodian that will serve as a single shareholder of record. These investors will be subject to the Custodian’s Account Agreement, including the electronic delivery of all required information.
The Total Amount Raised may include investments made outside of the SeedInvest platform via Regulation D. Off-platform investments from non-affiliates completed after the determination of the escrow target may be counted towards that escrow target.
BONUS PERK: Anyone who invests by Friday, December 9th, at 11:59pm ET will receive a 5% discount on a Zeen with free shipping (anyone who qualifies for a perk tier will receive an additional 5% off)
Anyone who invests between $5,000-$24,999 will receive a 10% discount on a Zeen with free shipping
Anyone who invests between $25,000-$49,999 will receive a 30% discount on a Zeen, free shipping, free car-lifter + cupholder
Anyone who invests between $50,000-$249,999 will receive a free autographed black Zeen, free shipping, free car-lifter, travel case + cupholder, and video factory tour with Garrett Brown
Anyone who invests $250,000+ will receive a free Zeen of any custom color, free shipping, free car-lifter, travel case + cupholder, plus an in-person factory tour and lunch with Garrett Brown – or Zoom get-together and tutorial
It is advised that you consult a tax professional to fully understand any potential tax implications of receiving investor perks before making an investment.
Please note that due to share price calculations, some final investment amounts may be rounded down to the nearest whole share - these will still qualify for the designated perk tier. Additionally, investors must complete the online process and receive an initial email confirmation by the deadline stated above in order to be eligible for perks.
The graph below illustrates theor the of Zeen by Exokinetics Inc.'s prior rounds by year.
As one-in-seven people worldwide risk losing mobility due to age, illness or injury, there exists a substantial need for assistive technology. Over 17 million Americans currently suffer from significant mobility loss -- 7.1% of the adult population -- and 6.8 million Americans already use assistive devices for mobility.
The aggregate disposable income of disabled Americans exceeds $500 billion annually. The North American wheelchair market size was valued at $943.1 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028.
Devices such as walkers, rollators and wheelchairs are in common use, but they either support users passively as they are seated or provide leaning support while standing. Standing supports tend to put the user in an unnatural walking position, slow users them down compared to the normal walking gait, and can be prone to falls.
The Company may be at risk for supply chain disruption since they source parts overseas.
The Company has entered into two loan agreements with the Company's largest shareholder.
Manufacturing or design defects, unanticipated use of the Company's products, or inadequate disclosure of risks relating to the use of the products could lead to injury or other adverse events. These events could lead to recalls or safety alerts relating to its products (either voluntary or required by governmental authorities) and could result, in certain cases, in the removal of a product from the market. Any recall could result in significant costs as well as negative publicity that could reduce demand for its products. Personal injuries relating to the use of its products could also result in product liability claims being brought against the Company. In some circumstances, such adverse events could also cause delays in new product approvals. Similarly, negligence in performing its services can lead to injury or other adverse events.
The Company has outstanding liabilities. The Company owes SLMC Finance Corporation $1,000,000 due on the earlier of (i) December 7, 2023, or (ii) after the occurrence of an Event of Default. The Company owes SLMC Finance corporation an additional $700,000 due on the earlier of (i) June 17, 2023, or (ii) after the occurrence of an Event of Default.
In June 2022, the Company obtained a second loan from one of its shareholders in the amount of $700,000. The loans interest at 8% per annum and matures one year from the date the note was issued.
The bad actor check uncovered negative news on a company affiliate. A company director was formally involved in a lawsuit with a former company. However, this finding is not disqualifying and he serves as CEO of a meaningful publicly traded company.
The Total Amount Raised, as reflected on the SeedInvest platform, may be partially comprised of investments from the Company’s management or affiliates. Such investments are not being counted towards the escrow minimum. If the sum of the investment commitments does not equal or exceed the escrow minimum at the offering end date, no securities will be sold in the offering, investment commitments will be cancelled, and committed funds will be returned. As a result, the Total Amount Raised may not be reflective of the Company's ability to conduct a closing.
The Accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has a net operating loss of $2,262,253, an operating cash flow loss of $2,396,252, and liquid assets in cash of $594,820, which less than a year’s worth of cash reserves as of December 31, 2021.These factors normally raise doubt about theCompany’s ability to continue as a going concern.
The Company’s ability to continue as a going concern in the next twelve months following the date the financial statements were available to be issued is dependent upon its ability to produce revenues and/or obtain financing sufficient to meet current and future obligations and deploy such to produce profitable operating results.
Management has evaluated these conditions and plans to generate revenues and raise capital as needed to satisfy its capital needs. During the next twelve months, the Company intends to fund its operations through debt and/or equity financing.
There are no assurances that management will be able to raise capital on terms acceptable to the Company. If it is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned development, which could harm its business, financial condition, and operating results. The accompanying financial statements do not include any adjustments that might result from these uncertainties.
On December 7, 2021, the Company entered into bridge loan in the amount of $1,000,000 with one of its shareholders. The loan bears interest of 10% per annum; provided, however, that in the event of the closing of a change of control (as defined in the agreement), the aggregate amount of interest accrued under this note since the issuance hereof shall be deemed to be not less than hundred fifty thousand dollars ($150,000). All unpaid principal, together with the balance of any unpaid interest, shall be due and payable on demand at any time after two years from the date of issuance of this loan, or an event of default (as defined in the agreement).
As of January 1, 2020, the Company had a loan with a shareholding in the amount of $183,195. During the year ended December 31, 2020, this loan was repaid in full.
The Company maintains its cash with a major financial institution located in the United States of America which it believes to be creditworthy. Balances are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, the Company may maintain balances in excess of the federally insured limits.
The Company has not filed a Form D for its Seed offering in February 2017 and Series A offering in February 2019. The SEC rules require a Form D to be filed by companies within 15 days after the first sale of securities in the offering relying on Regulation D. Failing to register with the SEC or get an exemption may lead to fines, the right of investors to get their investments back, and even criminal charges. There is a risk that a late penalty could apply.
The Company’s Board does not keep meeting minutes from its board meetings. Though the Company is a Delaware Corporation and Delaware does not legally require its corporations to record and retain meeting minutes, the practice of keeping board minutes is critical to maintaining good corporate governance. Minutes of meetings provide a record of corporate actions, including director and officer appointments and board consents for issuances, and can be helpful in the event of an audit or lawsuit. These recordkeeping practices can also help to reduce the risk of potential liability due to failure to observe corporate formalities, and the failure to do so could negatively impact certain processes, including but not limited to the due diligence process with potential investors or acquirers. There is no guarantee that the Company’s board will begin keeping board meeting minutes.
The development and commercialization of the Company’s products and services are highly competitive. It faces competition with respect to any products and services that it may seek to develop or commercialize in the future. Its competitors include major companies worldwide. The market the company is entering is an emerging industry where new competitors are entering the market frequently. Many of the Company’s competitors have significantly greater financial, technical and human resources and may have superior expertise in research and development and marketing approved services and thus may be better equipped than the Company to develop and commercialize services. These competitors also compete with the Company in recruiting and retaining qualified personnel and acquiring technologies. Smaller or early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. Accordingly, the Company’s competitors may commercialize products more rapidly or effectively than the Company is able to, which would adversely affect its competitive position, the likelihood that its services will achieve initial market acceptance and its ability to generate meaningful additional revenues from its products and services.
The Company’s expenses will significantly increase as they seek to execute their current business model. Although the Company estimates that it has enough runway until end of year, they will be ramping up cash burn to promote revenue growth, further develop R&D, and fund other Company operations after the raise. Doing so could require significant effort and expense or may not be feasible.
The Company’s success depends on the experience and skill of the board of directors, its executive officers and key employees. In particular, the Company is dependent on Garrett Brown, Ryan Meers, Eric Golden, and Jane Rosch. There can be no assurance that they will continue to be employed by the Company for a particular period of time. The loss of the Company’s key employees or any member of the board of directors or executive officer could harm the Company’s business, financial condition, cash flow and results of operations.
The Company projects aggressive growth in 2022. If these assumptions are wrong and the projections regarding market penetration are too aggressive, then the financial forecast may overstate the Company's overall viability. In addition, the forward-looking statements are only predictions. The Company has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
The company is offering preferred equity which poses unique risks. Preferred equity is usually issued to outside investors and carries rights and conditions that are different from that of common stock. For example, preferred equity may include rights that prevent or minimize the effects of dilution or grants special privileges in situations when the company is sold. However, while preferred equity holders will be compensated before common stockholders in the event of bankruptcy, they do not receive preference over creditors and bondholders. In addition, certain classes of preferred equity may not have any voting rights.
The outbreak of the novel coronavirus, COVID-19, has adversely impacted global commercial activity and contributed to significant declines and volatility in financial markets. The coronavirus pandemic and government responses are creating disruption in global supply chains and adversely impacting many industries. The outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown. The rapid development and fluidity of this situation precludes any prediction as to the ultimate material adverse impact of the novel coronavirus. Nevertheless, the novel coronavirus presents material uncertainty and risk with respect to the Funds, their performance, and their financial results.
Start-up investing is risky. Investing in startups is very risky, highly speculative, and should not be made by anyone who cannot afford to lose their entire investment. Unlike an investment in a mature business where there is a track record of revenue and income, the success of a startup or early-stage venture often relies on the development of a new product or service that may or may not find a market. Before investing, you should carefully consider the specific risks and disclosures related to both this offering type and the company which can be found in this company profile and the documents in the data room below.
Your shares are not easily transferable. You should not plan on being able to readily transfer and/or resell your security. Currently there is no market or liquidity for theseshares and the company does not have any plans to list these shares on an exchange or other secondary market. At some point the company may choose to do so, but until then you should plan to hold your investment for a significant period of time before a "liquidation event" occurs. A "liquidation event" is when the company either lists their shares on an exchange, is acquired, or goes bankrupt.
The Company may not pay dividends for the foreseeable future. Unless otherwise specified in the offering documents and subject to state law, you are not entitled to receive any dividends on your interest in the Company. Accordingly, any potential investor who anticipates the need for current dividends or income from an investment should not purchase any of the securities offered on the Site.
Valuation and capitalization. Unlike listed companies that are valued publicly through market-driven stock prices, the valuation of private companies, especially startups, is difficult to assess and you may risk overpaying for your investment. In addition, there may be additional classes of equity with rights that are superior to the class of equity being sold.
You may only receive limited disclosure. While the company must disclose certain information, since the company is at an early-stage they may only be able to provide limited information about its business plan and operations because it does not have fully developed operations or a long history. The company may also only be obligated to file information periodically regarding its business, including financial statements. A publicly listed company, in contrast, is required to file annual and quarterly reports and promptly disclose certain events through continuing disclosure that you can use to evaluate the status of your investment.
Investment in personnel. An early-stage investment is also an investment in the entrepreneur or management of the company. Being able to execute on the business plan is often an important factor in whether the business is viable and successful. You should be aware that a portion of your investment may fund the compensation of the company's employees, including its management. You should carefully review any disclosure regarding the company's use of proceeds.
Possibility of fraud. In light of the relative ease with which early-stage companies can raise funds, it may be the case that certain opportunities turn out to be money-losing fraudulent schemes. As with other investments, there is no guarantee that investments will be immune from fraud.
Lack of professional guidance. Many successful companies partially attribute their early success to the guidance of professional early-stage investors (e.g., angel investors and venture capital firms). These investors often negotiate for seats on the company's board of directors and play an important role through their resources, contacts and experience in assisting early-stage companies in executing on their business plans. An early-stage company may not have the benefit of such professional investors.
Frequently Asked Questions
A Side by Side offering refers to a deal that is raising capital under two offering types. This Side by Side offering is raising under Regulation CF and Rule 506(c) of Regulation D.
The Form C is a document the company must file with the Securities and Exchange Commission (“SEC”) which includes basic information about the company and its offering and is a condition to making a Reg CF offering available to investors. It is important to note that the SEC does not review the Form C, and therefore is not recommending and/or approving any of the securities being offered.
Before making any investment decision, it is highly recommended that prospective investors review the Form C filed with the SEC (included in the company's profile) before making any investment decision.
Rule 506(c) under Regulation D is a type of offering with no limits on how much a company may raise. The company may generally solicit their offering, but the company must verify each investor’s status as an accredited investor prior to closing and accepting funds. To learn more about Rule 506(c) under Regulation D and other offering types check out our blog and academy.
Title III of the JOBS Act outlines Reg CF, a type of offering allowing private companies to raise up to $5 million from all Americans. Prior capital raising options limited private companies to raising money only from accredited investors, historically the wealthiest ~2% of Americans. Like a Kickstarter campaign, Reg CF allows companies to raise funds online from their early adopters and the crowd. However, instead of providing investors a reward such as a t-shirt or a card, investors receive securities, typically equity, in the startups they back. To learn more about Reg CF and other offering types check out our blog and academy.
When you complete your investment on SeedInvest, your money will be transferred to an escrow account where an independent escrow agent will watch over your investment until it is accepted by Zeen by Exokinetics Inc.. Once Zeen by Exokinetics Inc. accepts your investment, and certain regulatory procedures are completed, your money will be transferred from the escrow account to Zeen by Exokinetics Inc. in exchange for your securities. At that point, you will be a proud owner in Zeen by Exokinetics Inc..
To make an investment, you will need the following information readily available:
- Personal information such as your current address and phone number
- Employment and employer information
- Net worth and income information
- Your accredited investor status
- Social Security Number or passport
- ABA bank routing number and checking account number (typically found on a personal check or bank statement) or debit card information, unless paying via a Wire transfer.
Non-accredited investors are limited in the amount that he or she may invest in a Reg CF offering during any rolling 12-month period:
- If either the annual income or the net worth of the investor is less than $107,000, the investor is limited to the greater of $2,200 or 5% of the greater of his or her annual income or net worth.
- If the annual income and net worth of the investor are both greater than $107,000, the investor is limited to 10% of the greater of his or her annual income or net worth, to a maximum of $107,000.
Separately, Zeen by Exokinetics Inc. has set a minimum investment amount of US $1,000.
Accredited investors do not have any investment limits.
You are a partial owner of the company, you do own securities after all! But more importantly, companies which have raised money via Regulation CF must file information with the SEC and post it on their websites on an annual basis. Receiving regular company updates is important to keep shareholders educated and informed about the progress of the company and their investment. This annual report includes information similar to a company’s initial Reg CF filing and key information that a company will want to share with its investors to foster a dynamic and healthy relationship.
In certain circumstances a company may terminate its ongoing reporting requirement if:
- The company becomes a fully-reporting registrant with the SEC
- The company has filed at least one annual report, but has no more than 300 shareholders of record
- The company has filed at least three annual reports, and has no more than $10 million in assets
- The company or another party purchases or repurchases all the securities sold in reliance on Section 4(a)(6)
- The company ceases to do business
However, regardless of whether a company has terminated its ongoing reporting requirement per SEC rules, SeedInvest works with all companies on its platform to ensure that investors are provided quarterly updates. These quarterly reports will include information such as: (i) quarterly net sales, (ii) quarterly change in cash and cash on hand, (iii) material updates on the business, (iv) fundraising updates (any plans for next round, current round status, etc.), and (v) any notable press and news.
Currently there is no market or liquidity for these securities. Right now Zeen by Exokinetics Inc. does not plan to list these securities on a national exchange or another secondary market. At some point Zeen by Exokinetics Inc. may choose to do so, but until then you should plan to hold your investment for a significant period of time before a “liquidation event” occurs. A “liquidation event” is when Zeen by Exokinetics Inc. either lists their securities on an exchange, is acquired, or goes bankrupt.
You can return to SeedInvest at any time to view your portfolio of investments and obtain a summary statement. If invested under Regulation CF you may also receive periodic updates from the company about their business, in addition to monthly account statements.
This is Zeen by Exokinetics Inc.'s fundraising profile page, where you can find information that may be helpful for you to make an investment decision in their company. The information on this page includes the company overview, team bios, and the risks and disclosures related to this investment opportunity. If the company runs a side by side offering that includes an offering under Regulation CF, you may also find a copy of the Zeen by Exokinetics Inc.'s Form C. The Form C includes important details about Zeen by Exokinetics Inc.'s fundraise that you should review before investing.
For offerings made under Regulation CF, you may cancel your investment at any time up to 48 hours prior to the offering end date or an earlier date set by the company. You will be sent a notification at least five business days prior to a closing that is set to occur earlier than the original stated end date giving you an opportunity to cancel your investment if you have not already done so. Once a closing occurs, and if you have not canceled your investment, you will receive an email notifying you that your securities have been issued. If you have already funded your investment, your funds will be promptly refunded to you upon cancellation. To cancel your investment, you may go to your account's portfolio page by clicking your profile icon in the top right corner.
If you invest under any other offering type, you may cancel your investment at any time, for any reason until a closing occurs. You will receive an email when the closing occurs and your securities have been issued. If you have already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To cancel your investment, please go to your account's portfolio page by clicking your profile icon in the top right corner.